Alvin Luk named CEO of HuidaGene
Plus:TScan’s MacBeath now permanent CEO; chair, CMO, seed money for InProTher
CRISPR company HuidaGene Therapeutics Co. Ltd. named co-founder Alvin Luk CEO and a director. Luk was CEO of Wuhan Neurophth Biological Technology Co. Ltd., and has held roles at Spark Therapeutics Inc., Biogen Inc. (NASDAQ:BIIB) and Bayer AG (Xetra:BAYN).
Gavin MacBeath became permanent CEO and a board member at TScan Therapeutics Inc. (NASDAQ:TCRX). MacBeath has served as acting CEO since David Southwell departed the company in March. He joined TScan as CSO in 2018 and added the role of COO in June 2022. The company is screening TCRs against a genome-wide library of antigens to systematically identify targets for T cell therapies that avoid off-target toxicities...